138 related articles for article (PubMed ID: 14726692)
21. CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner.
Prevo R; Pirovano G; Puliyadi R; Herbert KJ; Rodriguez-Berriguete G; O'Docherty A; Greaves W; McKenna WG; Higgins GS
Cell Cycle; 2018; 17(12):1513-1523. PubMed ID: 30045664
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
23. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines.
Wang W; Heideman L; Chung CS; Pelling JC; Koehler KJ; Birt DF
Mol Carcinog; 2000 Jun; 28(2):102-10. PubMed ID: 10900467
[TBL] [Abstract][Full Text] [Related]
24. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells.
Choi YH; Zhang L; Lee WH; Park KY
Int J Oncol; 1998 Aug; 13(2):391-6. PubMed ID: 9664138
[TBL] [Abstract][Full Text] [Related]
25. Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events.
De Boer L; Oakes V; Beamish H; Giles N; Stevens F; Somodevilla-Torres M; Desouza C; Gabrielli B
Oncogene; 2008 Jul; 27(31):4261-8. PubMed ID: 18372919
[TBL] [Abstract][Full Text] [Related]
26. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
Choi YH; Lee WH; Park KY; Zhang L
Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
[TBL] [Abstract][Full Text] [Related]
27. Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells.
Cai D; Latham VM; Zhang X; Shapiro GI
Cancer Res; 2006 Sep; 66(18):9270-80. PubMed ID: 16982772
[TBL] [Abstract][Full Text] [Related]
28. Human cyclin A is required for mitosis until mid prophase.
Furuno N; den Elzen N; Pines J
J Cell Biol; 1999 Oct; 147(2):295-306. PubMed ID: 10525536
[TBL] [Abstract][Full Text] [Related]
29. Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression.
Lindqvist A; van Zon W; Karlsson Rosenthal C; Wolthuis RM
PLoS Biol; 2007 May; 5(5):e123. PubMed ID: 17472438
[TBL] [Abstract][Full Text] [Related]
30. Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B.
Catania MG; Mischel PS; Vinters HV
J Neuropathol Exp Neurol; 2001 Jul; 60(7):711-23. PubMed ID: 11444800
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of Rho GTPases with Clostridium difficile toxin B impairs centrosomal activation of Aurora-A in G2/M transition of HeLa cells.
Ando Y; Yasuda S; Oceguera-Yanez F; Narumiya S
Mol Biol Cell; 2007 Oct; 18(10):3752-63. PubMed ID: 17634283
[TBL] [Abstract][Full Text] [Related]
32. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.
Castedo M; Perfettini JL; Roumier T; Yakushijin K; Horne D; Medema R; Kroemer G
Oncogene; 2004 May; 23(25):4353-61. PubMed ID: 15048074
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of mixed-lineage kinase (MLK) activity during G2-phase disrupts microtubule formation and mitotic progression in HeLa cells.
Cha H; Dangi S; Machamer CE; Shapiro P
Cell Signal; 2006 Jan; 18(1):93-104. PubMed ID: 15923109
[TBL] [Abstract][Full Text] [Related]
34. Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells.
Clemens DL; Calisto LE; Sorrell MF; Tuma DJ
Hepatology; 2003 Aug; 38(2):385-93. PubMed ID: 12883482
[TBL] [Abstract][Full Text] [Related]
35. Induction of G2/M phase arrest by squamocin in chronic myeloid leukemia (K562) cells.
Lu MC; Yang SH; Hwang SL; Lu YJ; Lin YH; Wang SR; Wu YC; Lin SR
Life Sci; 2006 Apr; 78(20):2378-83. PubMed ID: 16310807
[TBL] [Abstract][Full Text] [Related]
36. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
Schutte B; Nieland L; van Engeland M; Henfling ME; Meijer L; Ramaekers FC
Exp Cell Res; 1997 Oct; 236(1):4-15. PubMed ID: 9344580
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of mixed lineage kinase MLK3 by cyclin-dependent kinases CDK1 and CDK2 controls ovarian cancer cell division.
Cedeno-Rosario L; Honda D; Sunderland AM; Lewandowski MD; Taylor WR; Chadee DN
J Biol Chem; 2022 Aug; 298(8):102263. PubMed ID: 35843311
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors.
Legraverend M; Ludwig O; Bisagni E; Leclerc S; Meijer L; Giocanti N; Sadri R; Favaudon V
Bioorg Med Chem; 1999 Jul; 7(7):1281-93. PubMed ID: 10465404
[TBL] [Abstract][Full Text] [Related]
39. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells.
Motwani M; Li X; Schwartz GK
Clin Cancer Res; 2000 Mar; 6(3):924-32. PubMed ID: 10741717
[TBL] [Abstract][Full Text] [Related]
40. Active cyclin B1-Cdk1 first appears on centrosomes in prophase.
Jackman M; Lindon C; Nigg EA; Pines J
Nat Cell Biol; 2003 Feb; 5(2):143-8. PubMed ID: 12524548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
